Eloxx Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $306K, a 69.2% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $306K -$687K -69.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $481K -$678K -58.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $654K -$611K -48.3% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $825K -$618K -42.8% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 $993K -$624K -38.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.16M -$707K -37.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.27M +$976K +338% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $1.44M +$1.02M +243% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $1.62M +$1.07M +193% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $1.87M +$1.19M +175% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $289K -$533K -64.8% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $421K -$503K -54.4% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $551K -$319K -36.7% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $678K -$311K -31.4% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $822K -$284K -25.7% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $924K Dec 31, 2019 10-K 2021-03-12
Q3 2019 $870K Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $989K Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.11M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.